262 related articles for article (PubMed ID: 28669130)
61. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.
Uemura T; Ramprasad V; Matsushima K; Shike H; Valania T; Kwon O; Ghahramani N; Shah R; Farooq U; Khan A; Kadry Z
Transplantation; 2011 Sep; 92(6):678-85. PubMed ID: 21841541
[TBL] [Abstract][Full Text] [Related]
62. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.
Welberry Smith MP; Cherukuri A; Newstead CG; Lewington AJ; Ahmad N; Menon K; Pollard SG; Prasad P; Tibble S; Giddings E; Baker RJ
Transplantation; 2013 Dec; 96(12):1082-8. PubMed ID: 24056618
[TBL] [Abstract][Full Text] [Related]
63. An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.
Cherukuri A; Salama AD; Carter C; Smalle N; McCurtin R; Hewitt EW; Hernandez-Fuentes M; Clark B; Baker RJ
Am J Transplant; 2012 Apr; 12(4):919-31. PubMed ID: 22390816
[TBL] [Abstract][Full Text] [Related]
64. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
[TBL] [Abstract][Full Text] [Related]
65. Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
Kim IK; Choi J; Vo AA; Kang A; Patel M; Toyoda M; Mirocha J; Kamil ES; Cohen JL; Louie S; Galera O; Jordan SC; Puliyanda DP
Transplantation; 2017 Apr; 101(4):883-889. PubMed ID: 27495773
[TBL] [Abstract][Full Text] [Related]
66. Optimizing Immunosuppressive Regimens Among Living-Donor Renal Transplant Recipients.
Bakr MA; Nagib AM; Gheith OA; Hamdy AF; Refaie AF; Donia AF; Neamatalla AH; Eldahshan KF; Denewar AA; Abbas MH; Mostafa AI; Ghoneim MA
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):16-23. PubMed ID: 28260425
[TBL] [Abstract][Full Text] [Related]
67. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.
Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010253. PubMed ID: 24901467
[TBL] [Abstract][Full Text] [Related]
68. Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
Muthusamy AS; Vaidya AC; Sinha S; Roy D; Elker DE; Friend PJ
Am J Transplant; 2008 Oct; 8(10):2126-31. PubMed ID: 18828772
[TBL] [Abstract][Full Text] [Related]
69. Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.
Kaufman DB; Woodle ES; Shields AR; Leone J; Matas A; Wiseman A; West-Thielke P; Sa T; King EC; Alloway RR;
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1387-1397. PubMed ID: 34233921
[TBL] [Abstract][Full Text] [Related]
70. Alemtuzumab induction in deceased donor kidney transplantation.
Huang E; Cho YW; Hayashi R; Bunnapradist S
Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833
[TBL] [Abstract][Full Text] [Related]
71. Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
Furukawa M; Chan EG; Ryan JP; Hyzny EJ; Sacha LM; Coster JN; Pilewski JM; Lendermon EA; Kilaru SD; McDyer JF; Sanchez PG
Front Immunol; 2022; 13():864545. PubMed ID: 35720296
[TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation.
Bhoopalan SV; Cross SJ; Panetta JC; Triplett BM
Cancer Chemother Pharmacol; 2020 Dec; 86(6):711-717. PubMed ID: 33037919
[TBL] [Abstract][Full Text] [Related]
73. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.
Umber A; Killackey M; Paramesh A; Liu Y; Qin H; Atiq M; Lee B; Alper AB; Simon E; Buell J; Zhang R
J Nephrol; 2017 Apr; 30(2):289-295. PubMed ID: 27062485
[TBL] [Abstract][Full Text] [Related]
74. Alemtuzumab Induction Is Associated With an Equalization of Outcomes Between White and African American Kidney Transplant Recipients.
Brooks JT; Mitro G; DeLeonibus A; Qu W; Rees M; Nazzal M; Ortiz J
Exp Clin Transplant; 2019 Apr; 17(2):196-201. PubMed ID: 29206087
[TBL] [Abstract][Full Text] [Related]
75. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
76. Alemtuzumab in renal transplantation. Reviews of literature and usage in the United Kingdom.
Chukwu CA; Spiers HVM; Middleton R; Kalra PA; Asderakis A; Rao A; Augustine T
Transplant Rev (Orlando); 2022 Apr; 36(2):100686. PubMed ID: 35151219
[TBL] [Abstract][Full Text] [Related]
77. A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection.
van Vugt LK; van der Zwan M; Clahsen-van Groningen MC; van Agteren M; Hullegie-Peelen DM; De Winter BCM; Reinders MEJ; Miranda Afonso P; Hesselink DA
Transpl Int; 2023; 36():11834. PubMed ID: 38020744
[TBL] [Abstract][Full Text] [Related]
78. Alemtuzumab Induction and Steroid Minimization in IgA Nephropathy: A Matched-Cohort Analysis.
Becker K; Brooks J; Mitro G; Rees M; Ortiz J
Exp Clin Transplant; 2020 Dec; 18(7):751-756. PubMed ID: 31875465
[TBL] [Abstract][Full Text] [Related]
79. Immunosuppressive T-cell antibody induction for heart transplant recipients.
Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
[TBL] [Abstract][Full Text] [Related]
80. Association of More Intensive Induction With Less Acute Rejection Following Intestinal Transplantation: Results of 445 Consecutive Cases From a Single Center.
Vianna R; Farag A; Gaynor JJ; Selvaggi G; Tekin A; Garcia J; Beduschi T
Transplantation; 2020 Oct; 104(10):2166-2178. PubMed ID: 31929425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
